RapidAI Acquires EndoVantage
In 2019, RapidAI introduced Rapid ICH, the next step in AI-powered imaging technology for hemorrhages. Now with the acquisition of EndoVantage, the company will also add a concentration on aneurysm.
EKKDA Announces Sales-Distribution Agreement with OCuSOFT Inc.
According to Mr. Foster, given the established ophthalmic relationships both in ophthalmology and optometry, the EKKDA research projects will be focused primarily on eye care.
Sustained Acoustic Medicine Device sam® Offers an Alternative Solution to Pain Medication and Surgery
sam® is a non-invasive prescription medical device that is applied over the target injury and delivers a localized treatment.
CMS Approves SINUVA Sinus Implant for Reimbursement with New C-Code and Pass-Through Payment Status
SINUVA is a non-surgical, corticosteroid-eluting implant for the treatment of nasal polyps in adult patients who have had ethmoid sinus surgery.
CytoSorbents Awarded $2,897,172 Phase III STTR Contract
This follows the successful completion of Phase I and II STTR contracts of approximately $1.15 million with researchers at Penn State University, previously funded by the U.S. Army Medical Research Acquisition Activity (USAMRAA) and the U.S. Army Medical Research and Material Command (USAMRMC).